Prevalence of Plasmodium vivax Malaria among Children in Kassala State, Eastern Sudan

Mamoun Magzoub^1, , Mustafa A Alkawad¹, Mohamed A Mohamed^{1, 2}, Hamza M Ali¹, Abdallah M Osman¹, Elhady E Elmubarak¹, Shamselfalah M Osman¹ and Osman E Osman³

¹Faculty of Medicine, University of Kassala, Kassala, Sudan

²College of Medicine, University of Bisha, Bisha, Saudi Arabia

³Faculty of Medicine, Al-Neelain University, Khartoum, Sudan

Cite this paper:
Mamoun Magzoub, Mustafa A Alkawad, Mohamed A Mohamed, Hamza M Ali, Abdallah M Osman, Elhady E Elmubarak, Shamselfalah M Osman and Osman E Osman. Prevalence of Plasmodium vivax Malaria among Children in Kassala State, Eastern Sudan. American Journal of Microbiological Research. 2016; 4(6):164-167. doi: 10.12691/ajmr-4-6-1

Abstract

Background: All over the world 2.6 billion people per year are at risk of Plasmodium vivax malaria, 56% of all malaria cases outside Africa are due to Plasmodium vivax, also about 70-80 million malaria cases per year worldwide are due to Plasmodium vivax. To the best of our knowledge, there is no epidemiological study assessing the prevalence of Plasmodium vivax malaria in Sudan. Methods: This retrospective study was carried out at Kassala state, eastern Sudan. Thick and thin blood films were prepared from capillary blood sample from two thousand, eight hundred and seven febrile patients. The slides were stained with Giemsa and screened for the presence of malaria parasites and parasite species. Stained blood films were examined microscopically with (X100) oil immersion lens. Results: Plasmodium vivax was detected in 41 blood samples (1.5 %) when examined microscopically. Most of them 28 (1.0 %) were Rashieda tribe (p value = 0.03). Conclusion: The prevalence of Plasmodium vivax malaria was low in our study area comparing with the neighbor countries like Ethiopia. More researches can be performed in this area where Plasmodium falciparum is predominant.

Keywords:
vivax prevalence children Kassala Sudan

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Abdallah TM, Abdeen MT, Ahmed IS, Hamdan HZ, Magzoub M, and Adam I. Severe Plasmodium falciparum and Plasmodium vivax malaria among adults at Kassala Hospital, eastern Sudan. Malar J. 2013; 12: 148.
[2]	Naing C, Whittaker MA, Nyunt Wai V, Mak JW (2014) Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis. PLoS Negl Trop Dis 8(8): e3071.
[3]	Douglas NM, Anstey NM, Buffet PA, et al. The anaemia of Plasmodium vivax malaria. Malaria Journal 2012, 11:135.
[4]	Muhamad P, Ruengweerayut R, Chacharoenkul W, Rungsihirunra K, Na-Bangchang K. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010. Malaria Journal 2011, 10: 44.
[5]	Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77(Suppl 6):79-87.
[6]	Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F. the epidemiology of malaria in a Karen population on the western border of Thailand. Trans. R. Soc Trop Med Hyg 1996, 90:105-11.
[7]	Yangzom T, Gueye CS, Namgay R, Galappaththy GN, Thimasarn K, Gosling R, Murugasampillay S, Dev V: Malaria control in Bhutan: case study of a country embarking on elimination: Malar J. 2012. 9;11:9.
[8]	Mahgoub H, Gasim GI, Musa IR and Adam I. Severe Plasmodium vivax malaria among sudanese children at New Halfa Hospital, Eastern Sudan. Parasites & Vectors 2012, 5:154.
[9]	Maitland K, Williams TN, Bennett S et al. The interaction between Plasmodium falciparum and Plasmodium vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg. 1996; 90(6): 614-20.
[10]	Tong-Soo Kim,Hyung-Hwan Kim,Sun-Sim Lee2 et al. Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar. Malaria Journal 2010, 9:195.
[11]	YasinzaiM. Kakarsulemankhel J Prevalence of human malaria infection in bordering areas of East Balochistan, adjoining with Punjab: Loralai and Musakhel. Journal Pakistan medical association 2009; 59:132.
[12]	Jeanne, R, Fobia, W, Kenangalem, E, et al. Vivax Malaria, A Major Cause of Morbidity in Early Infancy. Clinical Infectious Diseases 2009 (48) 12:1704-1712.
[13]	Yasinzai MI, Kakarsulemankhel JK. Incidence of human malaria infection in central areas of Balochistan: Mastung and Khuzdar. Rawal Medical Journal. 2007; 32 (2): 176-178.
[14]	Awan Z, khan A, Shah A et al,Assessment Of Malaria Prevalence Among School Children In Rural Area Of Bannu Distrect Khyber Pakhtunkhwa, Pakistan, Pakistan J, zool 2012; 44(2): 321-326.
[15]	Tsige Ketema and Ketema Bacha. Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public Health 2013, 13:637.
[16]	Bassat Q (2011) The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria. PLoS Negl Trop Dis 5(12): e1325.
[17]	World Health Organization. Guidelines for Treatment of Malaria. 2nd ed. Geneva: WHO; 2O15.
[18]	Monica Cheesbrough. District Laboratory Practice in Tropical Countries Part 1, Second Edition, Cambridge University Press 2009; 245.
[19]	Kassa.D, Petros.B, Messele.T et al. Parasito-haematological features of acute Plasmodium falciparum and Plasmodium vivax malaria patients with and without HIV co-infection at Wonji Sugar Estate, Ethiopia. Ethiop.J.Health Dev. 2005; 19 (2):132-139.
[20]	Rodulfo.H, de Donato.M, Ada Peña. High prevalence of malaria infection in Amazonas state, Venezuela, Rev. Inst. Med. trop. S. Paulo 2007; (49)2: 79-85.
[21]	Bruno.B, Reis.A, Sebastião M et al. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malaria Journal 2010, 9:13.